Optometrist

Ocuphire Announces FDA Acceptance of New Drug Application and PDUFA Date of September 28, 2023 for Nyxol® Eye Drops for Reversal of Mydriasis

If Approved Later This Year, Nyxol Could be the Only Commercially Available Eye Drop for Reversal of DilationFARMINGTON HILLS, Mich.,…

1 year ago

Eye On Health Phoenix Offers New Expert Diabetic Eye Care Exams In Phoenix, Arizona

Phoenix, Arizona, Nov. 28, 2022 (GLOBE NEWSWIRE) -- Eye on Health Phoenix was founded in 2013 by Dr. Balocca, an…

1 year ago

NEXGEL Develops New Hydrogel Patch to Treat Amblyopia

Patch Will Be Available to Ophthalmologists and Optometrists in 1H 2023 Global Amblyopia Market Expected to Reach Over $6 Billion…

1 year ago

AXIM Biotechnologies Celebrates Feature on the Vision is More Than 20/20™ Podcast

SAN DIEGO, July 21, 2022 (GLOBE NEWSWIRE) -- AXIM Biotechnologies, Inc. (OTCQB: AXIM) (“AXIM Biotech,” “AXIM” or “the Company”), an…

2 years ago

Newly Launched Digital Platform for Optometrists Allows Patients to Safely Interact with Doctors

Opti-Xpres Offers Contactless Patient Scheduling, Paperwork, Payment Processing, and a Virtual Glasses Try-On Feature  PHOENIX – In an effort to…

4 years ago